Dr. Adly Thebaud

Psychiatry
Adly Thebaud,md,pa
1403 Medical Plz, Suite 202, 
Sanford, FL 
Accepting New Patients
Offers Telehealth
Adly Thebaud,md,pa
1403 Medical Plz, Suite 202, 
Sanford, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adly Thebaud is a Psychiatrist in Sanford, Florida. His top areas of expertise are Bipolar Disorder (BPD), Alzheimer's Disease, and Dementia. Dr. Thebaud is currently accepting new patients.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Psychiatry
Licenses
Psychiatry & Neurology in FL
Languages Spoken
English
French
Haitian
Haitian Creole
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Florida Health
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

ADLY THEBAUD,MD,PA
1403 Medical Plz, Suite 202, Sanford, FL 32771

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2024
Intervention Type: Drug
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
Enrollment Status: Terminated
Publish Date: May 09, 2024
Intervention Type: Drug
Study Drug: NaBen®
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
Enrollment Status: Completed
Publish Date: December 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Dr. Parikshit A. Deshmukh
Psychiatry
Expertise in
9
conditions
Dr. Parikshit A. Deshmukh
Psychiatry

Balanced Wellbeing LLC

3200 Sw 34th Ave, Suite 701, 
Ocala, FL 
 (59.0 miles away)
877-779-2429
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Parikshit Deshmukh is a Psychiatrist in Ocala, Florida. Dr. Deshmukh is highly rated in 9 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Dementia, and Pseudobulbar Affect. Dr. Deshmukh is currently accepting new patients.

Expertise in
5
conditions
Dr. Aftab Qadir
Psychiatry
Expertise in
5
conditions
Dr. Aftab Qadir
Psychiatry

Tri County Psychiatric Associates, P.A.

101 E Miller St, 
Orlando, FL 
 (20.7 miles away)
407-246-6620
Experience:
43+ years
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Aftab Qadir is a Psychiatrist in Orlando, Florida. Dr. Qadir has been practicing medicine for over 43 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizoaffective Disorder, and Schizophrenia. Dr. Qadir is currently accepting new patients.

Expertise in
10
conditions
Dr. Gary W. Frick
Psychiatry
Expertise in
10
conditions
Dr. Gary W. Frick
Psychiatry
804 Dunlawton Ave, Suite 1, 
Port Orange, FL 
 (27.9 miles away)
386-767-8584
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Frick is a Psychiatrist in Port Orange, Florida. Dr. Frick is highly rated in 10 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Bipolar Disorder (BPD), and Generalized Anxiety Disorder (GAD). Dr. Frick is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thebaud's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile